Andrew Witty articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/18 01:43
2013/05/18 01:43
3d
Why 50-something CEOs are quitting their jobs
LONDON - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief...
3
RELATED
Peter Voser Tullow Oil London ABB Joe Hogan
MENTIONED
2013/05/18 01:43
2013/05/18 01:43
Latest videos
2013/05/18 01:43
2013/05/18 01:43
Latest from Twitter
2013/05/10 11:52
2013/05/10 11:52
11d
Glaxo, Merck in plan to send vaccine to Africa
Multinational drug companies, like other businesses, see Africa as an emerging market with tremendous opportunities and challenges, and that was a backdrop to Thursday's announcements of two programs...
Merck & Co. GlaxoSmithKline PLC Cape Town NAIROBI Andrew Witty
MENTIONED
2013/05/10 02:36
2013/05/10 02:36
11d
Drug firm launches Africa initiative
Share this page New medicines will be sold at cost price with any profits reinvested in research GlaxoSmithKline and the charity said together they could save a million children's lives. Save the...
GlaxoSmithKline Save The Children Justin Forsyth Andrew Witty BBC
MENTIONED
2013/05/09 19:34
2013/05/09 19:34
11d
Drug company to partner Africa NGO
Children stand on a street in front of their house at Mishomoroni area of Kenya's coastal city of Mombasa. REUTERS/Marko Djurica Naiorobi, Kenya - GlaxoSmithKline is giving Save the Children $23...
9
RELATED
GlaxoSmithKline Save The Children Andrew Witty GSK NAIROBI
MENTIONED
2013/05/01 12:58
2013/05/01 12:58
20d
Glaxo hit by US regulatory delay
The US Food and Drug Administration (FDA) moved the date when it will votes on whether to approve or reject GSK�s experimental cancer drug Trametinib back to September 3rd 2013. The Prescription Drug...
US Food and Drug Administration Andrew Witty GlaxoSmithKline
MENTIONED
2013/04/26 12:11
2013/04/26 12:11
25d
The fight for global immunisation
Can funding keep pace with the will to vaccinate every child worldwide? It is universally recognised as one of the most successful and cost effective health programmes in the world. Immunising...
67
RELATED
MOGADISHU United Nations International Children's Emergency Fund World Health Organization Abu Dhabi al-Shabab
MENTIONED
2013/04/25 10:52
2013/04/25 10:52
26d
Glaxo may sell older drug brands
After reporting lower quarterly profits, drugmaker GlaxoSmithKline said Wednesday that it would reorganize its pharmaceutical divisions, with the possibility of someday selling older, "established"...
Andrew Witty U.S. Supreme Court GlaxoSmithKline Glaxo London
MENTIONED
2013/04/25 04:21
2013/04/25 04:21
26d
Sale of drinks brands could net Glaxo £1bn
Sale of drinks brands could net Glaxo £1bn John Collingridge bustel@belfasttelegraph.co.uk – 25 April 2013 Popular drinks brands Ribena and Lucozade have been put up for sale in a move which could...
GlaxoSmithKline Glaxo London Andrew Witty iPad
MENTIONED
2013/04/24 17:51
2013/04/24 17:51
27d
GSK puts Lucozade and Ribena drink brands up for ...
GSK puts Lucozade and Ribena drink brands up for sale LONDON (Reuters) - GlaxoSmithKline (GSK.L) is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion...
5
RELATED
GlaxoSmithKline GSK Lucozade London CVC Capital Partners
MENTIONED
2013/04/24 16:19
2013/04/24 16:19
27d
Drugmaker GSK posts slumping Q1 profits
British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate. GSK, which also has a...
Andrew Witty GlaxoSmithKline Lucozade London
MENTIONED
2013/04/24 14:43
2013/04/24 14:43
27d
GSK Put Iconic Soft Drink Brands Up For Sale
Chief executive of GSK, Sir Andrew Witty, said it hoped to sell the brands to a global drinks giant. "[We] concluded that the tremendous growth potential of these iconic brands, particularly outside...
Andrew Witty GSK
MENTIONED
2013/04/24 14:33
2013/04/24 14:33
27d
GSK: reforms on track as Q1 profit falls a quarter
LONDON (AP) Pharmaceutical company GlaxoSmithKline has reported a 26 percent drop in profits in the first quarter compared to a year ago, as it restructures its manufacturing and research and...
4
RELATED
GlaxoSmithKline London Andrew Witty The Associated Press
MENTIONED
2013/04/24 12:58
2013/04/24 12:58
27d
GSK advances on plans to sell Lucozade and Ribena...
Some analysts have suggested that the decision to sell the brands could earn the company in the region of �1.0bn. GSK said that the results reflected the ongoing contribution from 'key growth...
GlaxoSmithKline Andrew Witty
MENTIONED
2013/04/24 12:13
2013/04/24 12:13
27d
Ulverston employer Glaxo Smith Kline announces fi...
Last updated at 12:51, Wednesday, 24 April 2013 GLAXO Smith Kline has today announced its results for the first quarter of 2013. It has delivered first quarter core Earnings Per Share (EPS) of 26.9p...
Andrew Witty GSK Advisory Committee FDA
MENTIONED
2013/04/19 22:21
2013/04/19 22:21
1m
At the drug barons' mercy / Comment / World / Bri...
However, this assertion seems to depend largely on the statement that its conduct has already been investigated by the European Commission, which "concluded its inquiry with no further...
NHS European Commission Norton Wellbutrin Andrew Witty
MENTIONED
2013/04/19 22:20
2013/04/19 22:20
1m
Drugs giant accused of milking NHS for millions /...
Glaxo is alleged to have offered "substantial" payments to rivals Alpharma, Generics and Norton Healthcare to hold off from supplying cheaper versions of Seroxat. The Office of Fair Trading said...
33
RELATED
Office of Fair Trading GlaxoSmithKline Seroxat London Glaxo
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.